“…Isolated from fungus CL39457, antibiotic CJ‐16,2641 ( 1 , Figure 1 A) was reported to exhibit impressive activities against drug‐resistant Gram‐positive bacteria such as Staphylococcus aureus 01A1120 (MIC=0.78 μg mL −1 ) and Gram‐negative bacteria such as Moraxella catarrhalis 87A1055 (MIC=0.39 μg mL −1 ) and Escherichia coli 51A1051 with altered permeability (MIC=6.25 μg mL −1 ). The assigned structure of this molecule is intriguing in that it is amongst the most complex of its relatives, CJ‐16,367 [ 2 , Figure 1 A, stereochemistry unassigned, isolated from the same fungus (CL39457)],1 UCS1025A ( 3 , Figure 1 A)2 and UCS1025B ( 4 , Figure 1 A),2 21‐( S )‐ and 21‐( R )‐myceliothermophins C ( 5 a )3, 4 and D ( 5 b )3, 4 (Figure 1 B), and the most recently reported antibiotic pyrrolizilactone5 ( 1 a , Figure 1 A). Antibiotic CJ‐16,264 ( 1 ) possesses a challenging tetramethylated decalin system, whose relative and absolute configurations differ from those of its less complex siblings UCS compounds ( 3 and 4 ), and the myceliothermophins C ( 5 a ) and D ( 5 b ) (see Figure 1).…”